Trial intelligence / Profile preview

Phase 2 study of INCB054828 in previously treated advanced cholangiocarcinoma with FGFR alterations

NL-OMON44339Phase 2Withdrawn

Sponsor

IQVIA

Start

Jun 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1